Spago Nanomedical AB SPAGO

LUND, SE / ACCESS Newswire / September 29, 2026 / AB (publ) (STO:SPAGO.F) today announces that the company will participate in five international conferences during autumn 2026, spanning nuclear medicine, radionuclide therapy and life science.

LUND, SE / ACCESS Newswire / September 21, 2026 / (STO:SPAGO.F) - The shareholders of AB (publ), corporate registration number 556574-5048, are hereby summoned to the Extraordinary General Meeting on Thursday 22 October 2026, at 13.

LUND, SE / ACCESS Newswire / August 20, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) APRIL - JUNE IN BRIEF Net sales for the quarter amounted to KSEK 0 (KSEK 81) The loss for the quarter amounted to KSEK -7,331 (KSEK -6,964) Operating expenses ...

LUND, SE / ACCESS Newswire / June 10, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - The Annual General Meeting (AGM) of Spago Nanomedical AB (publ) was held today, June 10, 2026, at which the AGM resolved to approve the income statement and ...

NOT INTENDED FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR NEW ZEALAND OR IN ANY OTHER JURISDICTION ...

NOT INTENDED FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR NEW ZEALAND OR IN ANY OTHER JURISDICTION ...

LUND, SE / ACCESS Newswire / May 18, 2026 / Spago Nanomedical AB (publ)(STO:SPAGO.ST)(FRA:7UX.F) today announces that case findings from its ongoing Phase I/IIa clinical study Tumorad-01 have been presented at the 56th Annual Scientific Meeting of ...